TP53 and non-small cell lung carcinoma: TP53 mutation is an adverse prognostic factor for advanced non-small-cell lung cancer (NSCLC) (Jiao et al., 2018) and a hallmark event of advanced sporadic colon cancer (Watanabe et al., 2019).